Clinical Services > Pain management

Nerve pain drugs found to increase hip fracture risk in older adults

14 November, 2024

Often seen as a safer alternative to opioids for the treatment of neuropathic pain, the use of gabapentinoids increased eightfold between 2012 and 2018.


Brain activity can help predict chronic pain a few days after injury

30 October, 2024

After only one to three days of a whiplash injury, scientists can predict which patients will develop chronic pain based on the extent of 'cross-talk' between two regions of the brain.


Haleon, University of Sydney partner for osteoarthritis research

10 October, 2024

The program will investigate the therapeutic role of supplements in managing osteoarthritis symptoms and digital health technologies that improve mobility.


Are triptans more effective for acute migraines?

20 September, 2024

While there are numerous drugs available for migraines, there's no clear consensus on which ones perform best.


Rethink investigations and referrals for knee pain, emphasises new standard

15 August, 2024

A revised national standard outlines the right way to care for knee osteoarthritis, reflecting solid evidence of strong health outcomes without surgery.


Confronting trauma alleviates chronic pain: study

14 June, 2024

Psychotherapy that works by confronting past trauma and stress-related emotions that can exacerbate pain symptoms could help reduce chronic pain.


Post-hospital prescription opioid use: what do the statistics say?

29 May, 2024

Until recently, Australia's use of prescription opioids was increasing, and with it worries about dependence, overdose and death.


AI in health: CSIRO report highlights opportunities, challenges

27 March, 2024

The use of AI in health care is unique because the accuracy of models could mean the difference between life and death, or ongoing health and illness, said Dr David Hansen.


Opioids: did PBS restrictions reduce use in Australia?

25 March, 2024

Subsidised opioid use has dropped overall, but use of one opioid is still on the rise, reveals a new study.


Digital therapy reduces distress in long-term conditions

15 February, 2024

People living with long-term conditions who received the therapist-guided digital program have showed a significant reduction in psychological distress.


Cannatrek signs MoU to advance medicinal cannabis research

31 January, 2024

Cannatrek has signed an agreeent with Mie University in Tsu, Japan, to forge an open collaboration focused on accelerating medical research.


Low back pain heals the fastest in the first 6 weeks: study

24 January, 2024

Most people who experience severe and sudden back pain begin to improve within the first six weeks, but many will go on to have ongoing pain according to latest research.


Lenexa Medical LenexaCARE pressure injury monitoring system

05 December, 2023

The LenexaCARE fabric-based sensor technology paired with AI software monitors patient position and pressures in real time to enable personalised pressure injury prevention.


New adaptive clinical trial for progressive MS

29 November, 2023

An adaptive clinical trial for Australians living with MS is hoping to reverse neurological damage caused by progressive multiple sclerosis.


Novel intervention to improve strength, mobility in rheumatoid arthritis

06 November, 2023

A novel exercise intervention being trialled by the University of South Australia researchers, in partnership with Arthritis SA, could help improve physical function and quality of life in people.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd